Clinical Trial Update: Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating whether endothelin receptor blockade can provide bronchoprotective effects in asthma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Endothelin receptor antagonist (unspecified)

Snippet

Sponsor: University of Glasgow | Conditions: Asthma | Phase 2 | Status: UNKNOWN